Vinflunine

DB11641ApprovedInvestigationalSmall molecule

Vinflunine is a vinca alkaloid used to treat advanced or metastatic transitional cell carcinoma of the urothelial tract after a platinum containing treatment has failed. Vinflunine is a third-generation member of the vinca alkaloid family with anti-tumour actions.

Chemical structure of Vinflunine
Mechanism
Curator reviewed · 8 references
Primary indication
For use as a monotherapy in adults with advanced or transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing therapy.Curator reviewed · 2 structured indications
Formula / weight
C45H54F2N4O8 · 816.944 g/mol (avg)
First approval
European Union, 2016
Brand names
  • Javlor

Resolves to

Clinical / RWD
Structure
InChIKeyNMDYYWFGPIMTKO-KLCPSUAYSA-NSMILESCC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1=CC(OC)=C(C=C41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CC3=C1NC1=CC=CC=C31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC
Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
657Drug interactionsStructured to mechanism, not free text
Sign in
32Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
27Marketed productsAcross 4 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vinflunine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account